Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZAMBONEY: Fulvestrant and ZACTIMA in Bone-Predominant Metastatic Breast Cancer
NCT00811369Phase 2Completed
- Sponsor
- Ontario Clinical Oncology Group
- Start
- Aug 2009
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vandetanib in breast cancer, sponsored by Ontario Clinical Oncology Group. Started Aug 2009; status: completed.
02
Drugs
vandetanib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00811369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00811369.